Agree - some hurdles - but again - drug works - ti
Post# of 148292
As you mentioned, near catalysts would be clinical hold lift, likely followed quickly by financing and/or NASH trial design and/or NASH trial partnership, with Amarex in the background (which could be a game changer if it's a windfall or insignificant which still doesn't change the long term gameplan).
Should again be a multi-billion dollar valuation eventually, just a matter of when & how.